Oncological patients with endocrine complications after immunotherapy with checkpoint inhibitors present longer progression free and overall survival

Stavroula Α. Paschou; Michalis Liontos; Evangelos Eleftherakis-Papaiakovou; Katerina Stefanaki; Christos Markellos; Konstantinos Koutsoukos; Flora Zagouri; Θεοδώρα Ψαλτοπούλου; Meletios A Dimopoulos

doi:10.1530/endoabs.81.rc6.7

Shared by

Meletios A Dimopoulos

Oncological patients with endocrine complications after immunotherapy with checkpoint inhibitors present longer progression free and overall survival

Article 2022 en

Authors

SP
Stavroula Α. Paschou
ML
Michalis Liontos
EE
Evangelos Eleftherakis-Papaiakovou

Abstract

1 min read

Searchable abstracts of presentations at key conferences in endocrinology ISSN 1470-3947 (print) | ISSN 1479-6848 (online)

Related publications

Article2022

Patients with autoimmune thyroiditis present similar immunological response to COVID-19 BNT162b2 mRNA vaccine with healthy subjects, but vaccination may affect thyroid function

Stavroula Α. Paschou, Vangelis Karalis, Θεοδώρα Ψαλτοπούλου, Vasiliki Vasileiou, Ioanna Charitaki, Tina Bagratuni, Vassiliki Ktena, Fotini Papandroulaki, Sentiljana Gumeni, Georgia Kassi, Ioannis P. Trougakos, Evangelos Terpos, Meletios A Dimopoulos

Article2017

Endocrine manifestations of multisystem Langerhans cell histiocytosis

Diana Oliveira, Flavia Napoli, Enrica Bertelli, Aldo Maggioni, Sandra Paiva, Francisco Carrilho, Natascia Di Iorgi

Article2024

A Novel CDKN1B mutation in multiple endocrine neoplasia type 4

Christina Millou, George Chrousos, Amalia Sertedaki

Article2019

High prevalence of autonomous aldosterone secretion in patients with type 2 Diabetes Mellitus and arterial hypertension. The effect of SGLT2 inhibitors on renin-angiotensin-aldosterone system

Ernestini Tyfoxylou, Labrini Papanastasiou, George Piaditis, Nikolaos Voulgaris, George Chrousos, Theodora Kounadi

Article2024

Appraisal of modified tests for the diagnosis and treatment of primary aldosteronism: A single endocrine center experience

Αthina Markou, Gregory Kaltsas, Labrini Papanastasiou, Nikolaos Voulgaris, Aggeliki Gouli, Vaios Tsiavos, Christos Gravvanis, Ernestini Tyfoxylou, Sofia Vlachou, Chara Kapsali, Irini Giagourta, Theodora Kounadi, Kyriakos Vamvakidis, George Zografos, George Chrousos, George Piaditis

Oncological patients with endocrine complications after immunotherapy with checkpoint inhibitors present longer progression free and overall survival

Abstract

Discussion(0)

Related publications

Patients with autoimmune thyroiditis present similar immunological response to COVID-19 BNT162b2 mRNA vaccine with healthy subjects, but vaccination may affect thyroid function

Endocrine manifestations of multisystem Langerhans cell histiocytosis

A Novel CDKN1B mutation in multiple endocrine neoplasia type 4

High prevalence of autonomous aldosterone secretion in patients with type 2 Diabetes Mellitus and arterial hypertension. The effect of SGLT2 inhibitors on renin-angiotensin-aldosterone system

Appraisal of modified tests for the diagnosis and treatment of primary aldosteronism: A single endocrine center experience